Reviev paper<br>Antinuclear antibodies in Sjögren’s syndrome: antigen specificity and clinical significance

Mariusz Puszczewicz

Abstract

4/2006 vol. 44

Reviev paperAntinuclear antibodies in Sjögren’s syndrome: antigen specificity and clinical significance

Mariusz Puszczewicz

RU 2006; 44, 4: 226-229

Online publish date: 2006/09/04

View full text

AMA

Puszczewicz M. Reviev paperAntinuclear antibodies in Sjögren’s syndrome: antigen specificity and clinical significance. Reumatologia/Rheumatology. 2006;44(4):226-229.

APA

Puszczewicz, M. (2006). Reviev paperAntinuclear antibodies in Sjögren’s syndrome: antigen specificity and clinical significance. Reumatologia/Rheumatology, 44(4), 226-229.

Chicago

Puszczewicz, Mariusz. 2006. "Reviev paperAntinuclear antibodies in Sjögren’s syndrome: antigen specificity and clinical significance". Reumatologia/Rheumatology 44 (4): 226-229.

Harvard

Puszczewicz, M. (2006). Reviev paperAntinuclear antibodies in Sjögren’s syndrome: antigen specificity and clinical significance. Reumatologia/Rheumatology, 44(4), pp.226-229.

MLA

Puszczewicz, Mariusz. "Reviev paperAntinuclear antibodies in Sjögren’s syndrome: antigen specificity and clinical significance." Reumatologia/Rheumatology, vol. 44, no. 4, 2006, pp. 226-229.

Vancouver

Puszczewicz M. Reviev paperAntinuclear antibodies in Sjögren’s syndrome: antigen specificity and clinical significance. Reumatologia/Rheumatology. 2006;44(4):226-229.

This article briefly reviews the structure and function of molecules targeted by antinuclear antibodies specific for Sjögren’s syndrome. It also discusses ANA clinical relationships and methods of their detection.